Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberta Zanotti

Showing results (21-30 of 78) with videos related to

Pageof 8
Sort By:
Therapeutic Advances in Hematology|November 6, 2023
The clinical experience of compassionate use program for avapritinib: implications for drug positioning in the therapeutic scenario of systemic mastocytosisFrancesco Mannelli, Francesca Crupi, Roberta Zanotti, et al.
American Journal of Hematology|June 25, 2010
ZAP-70 expression is associated with increased risk of autoimmune cytopenias in CLL patientsRoberta Zanotti, Franzesco Frattini, Paolo Ghia, et al.
Cytometry. Part B, Clinical Cytometry|June 10, 2011
Primary role of multiparametric flow cytometry in the diagnostic work-up of indolent clonal mast cell disordersOmar Perbellini, Alberto Zamò, Sabrina Colarossi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2013
Combination of rituximab, bendamustine, and cytarabine for patients with mantle-cell non-Hodgkin lymphoma ineligible for intensive regimens or autologous transplantationCarlo Visco, Silvia Finotto, Renato Zambello, et al.
The Journal of Allergy and Clinical Immunology|December 12, 2018
Adverse reactions to drugs and biologics in patients with clonal mast cell disorders: A Work Group Report of the Mast Cells Disorder Committee, American Academy of Allergy, Asthma & ImmunologyMelody C Carter, Dean D Metcalfe, Almudena Matito, et al.
Allergy|October 21, 2025
Safety of Drug Provocation Tests in Adults With and Without Clonal Mast Cell DisordersFrancesca Nalin, Bianca Olivieri, Francesco Olivieri, et al.
British Journal of Haematology|June 17, 2004
Most cases of primary salivary mucosa-associated lymphoid tissue lymphoma are associated either with Sjoegren syndrome or hepatitis C virus infectionAchille Ambrosetti, Roberta Zanotti, Cristian Pattaro, et al.
Hematological Oncology|September 17, 2019
Systemic mastocytosis associated with myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis: Report of three casesElda Mimiola, Riccardo Bomben, Giovanna De Matteis, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 26, 2014
Venom immunotherapy in patients with clonal mast cell disorders: efficacy, safety, and practical considerationsPatrizia Bonadonna, David Gonzalez-de-Olano, Roberta Zanotti, et al.
American Journal of Hematology|May 7, 2019
Myelodysplasia as assessed by multiparameter flow cytometry refines prognostic stratification provided by genotypic risk in systemic mastocytosisFrancesco Mannelli, Francesca Gesullo, Giada Rotunno, et al.
Pageof 8

Showing results (21-30 of 78) with videos related to

Sort By:
Pageof 8
Therapeutic Advances in Hematology|November 6, 2023
The clinical experience of compassionate use program for avapritinib: implications for drug positioning in the therapeutic scenario of systemic mastocytosisFrancesco Mannelli, Francesca Crupi, Roberta Zanotti, et al.
American Journal of Hematology|June 25, 2010
ZAP-70 expression is associated with increased risk of autoimmune cytopenias in CLL patientsRoberta Zanotti, Franzesco Frattini, Paolo Ghia, et al.
Cytometry. Part B, Clinical Cytometry|June 10, 2011
Primary role of multiparametric flow cytometry in the diagnostic work-up of indolent clonal mast cell disordersOmar Perbellini, Alberto Zamò, Sabrina Colarossi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2013
Combination of rituximab, bendamustine, and cytarabine for patients with mantle-cell non-Hodgkin lymphoma ineligible for intensive regimens or autologous transplantationCarlo Visco, Silvia Finotto, Renato Zambello, et al.
The Journal of Allergy and Clinical Immunology|December 12, 2018
Adverse reactions to drugs and biologics in patients with clonal mast cell disorders: A Work Group Report of the Mast Cells Disorder Committee, American Academy of Allergy, Asthma & ImmunologyMelody C Carter, Dean D Metcalfe, Almudena Matito, et al.
Allergy|October 21, 2025
Safety of Drug Provocation Tests in Adults With and Without Clonal Mast Cell DisordersFrancesca Nalin, Bianca Olivieri, Francesco Olivieri, et al.
British Journal of Haematology|June 17, 2004
Most cases of primary salivary mucosa-associated lymphoid tissue lymphoma are associated either with Sjoegren syndrome or hepatitis C virus infectionAchille Ambrosetti, Roberta Zanotti, Cristian Pattaro, et al.
Hematological Oncology|September 17, 2019
Systemic mastocytosis associated with myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis: Report of three casesElda Mimiola, Riccardo Bomben, Giovanna De Matteis, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 26, 2014
Venom immunotherapy in patients with clonal mast cell disorders: efficacy, safety, and practical considerationsPatrizia Bonadonna, David Gonzalez-de-Olano, Roberta Zanotti, et al.
American Journal of Hematology|May 7, 2019
Myelodysplasia as assessed by multiparameter flow cytometry refines prognostic stratification provided by genotypic risk in systemic mastocytosisFrancesco Mannelli, Francesca Gesullo, Giada Rotunno, et al.
Pageof 8